AU Patent

AU2002323873B2 — Active ingredient combination of E.G. galanthamine or deoxypeganine and E.G. acamprosate or memantine for treating an addiction such as alcoholism

Assigned to HF Arzneimittelforschung GmbH and Co KG · Expires 2006-11-16 · 20y expired

What this patent protects

Patent listed against amantadine-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
AU2002323873B2
Jurisdiction
AU
Classification
—
Expires
2006-11-16
Drug substance claim
No
Drug product claim
No
Assignee
HF Arzneimittelforschung GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.